- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Hong Kong Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Results
19
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
19 companies
Hansoh Pharmaceutical Group
Market Cap: HK$234.7b
An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.
3692
HK$38.76
7D
-1.5%
1Y
71.5%
Innovent Biologics
Market Cap: HK$153.6b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.
1801
HK$88.50
7D
-3.3%
1Y
85.3%
WuXi Biologics (Cayman)
Market Cap: HK$148.5b
An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.
2269
HK$35.90
7D
2.6%
1Y
80.0%
Akeso
Market Cap: HK$127.3b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$138.20
7D
-1.6%
1Y
68.1%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$115.0b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$493.00
7D
-2.1%
1Y
63.2%
CSPC Pharmaceutical Group
Market Cap: HK$105.9b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$9.26
7D
-4.6%
1Y
75.7%
WuXi XDC Cayman
Market Cap: HK$79.3b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$63.00
7D
3.0%
1Y
87.2%
Genscript Biotech
Market Cap: HK$28.0b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$12.81
7D
3.6%
1Y
22.9%
Duality Biotherapeutics
Market Cap: HK$27.3b
A clinical-stage biotech company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others.
9606
HK$303.00
7D
-6.4%
1Y
n/a
Grand Pharmaceutical Group
Market Cap: HK$24.0b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$6.86
7D
-5.0%
1Y
16.1%
Keymed Biosciences
Market Cap: HK$22.1b
A biotechnology company, engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas in Mainland China and internationally.
2162
HK$75.00
7D
5.1%
1Y
71.0%
GenFleet Therapeutics (Shanghai)
Market Cap: HK$14.5b
Operates as a biopharmaceutical company that focuses on developing novel treatment options in the fields of oncology that cover different lines of treatments of multiple solid tumors, as well as autoimmune and inflammatory diseases.
2595
HK$39.26
7D
7.6%
1Y
n/a
CanSino Biologics
Market Cap: HK$13.1b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$32.74
7D
-0.9%
1Y
10.2%
Ocumension Therapeutics
Market Cap: HK$6.6b
Operates as an ophthalmic pharmaceutical platform company in the People's Republic of China.
1477
HK$8.10
7D
-5.4%
1Y
69.8%
Essex Bio-Technology
Market Cap: HK$1.9b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$3.36
7D
-7.2%
1Y
-22.2%
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$1.7b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$1.12
7D
-3.4%
1Y
-0.9%
Uni-Bio Science Group
Market Cap: HK$609.1m
An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.
690
HK$0.10
7D
2.0%
1Y
52.2%
Wai Yuen Tong Medicine Holdings
Market Cap: HK$401.2m
An investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong.
897
HK$0.36
7D
-2.7%
1Y
5.9%
Tianda Pharmaceuticals
Market Cap: HK$208.6m
Engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia.
455
HK$0.097
7D
0%
1Y
-28.7%